U.S. Colorectal Cancer Markets - Patient Outlook


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service provides the patient outlook and forecast for colorectal cancer in the U.S. from 2003-2013. The patient population is discussed in terms of staging and line of therapy.

Table of Contents

U.S. Colorectal Cancer Markets - Patient Outlook, Executive SummaryExecutive SummaryIntroductionColorectal Cancer Market Update InformationOverviewU.S. Colorectal Cancer Markets - Patient Outlook, Patient Forecasts and StagingForecastsIncidence and Staging ForecastsPatient Forecasts by Line of TherapyU.S. Colorectal Cancer Markets - Patient Outlook, AppendixDecision Support DatabasesRed Meat ConsumptionColorectal Cancer MortalitySmoker PrevalencePharmaceutical R&D ExpenditureGovernment R&D Expenditure in Biotechnology

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.